Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Detection of B-cell activating factor as a biomarker for antibody mediated rejection in transplant recipients

Detection of B-cell activating factor as a biomarker for antibody mediated rejection in transplant recipients

US Patent 9176147 · Granted Nov 3, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

In vivo gene therapy delivery procedure and device2025
Hepatocyte based insulin gene therapy for diabetes2024
Methods of T cell expansion and activation2024
In vivo therapeutic delivery procedure and device2023
In vivo gene therapy delivery procedure and device2021
Methods of T cell expansion and activation2020
Hepatocyte based insulin gene therapy for diabetes2019
Hepatocyte based insulin gene therapy for diabetes2017
Treatment of diabetes with synthetic beta cells2008
Treatment of diabetes with synthetic beta cells2005
Anergy associated genes2004
Treatment of diabetes with synthetic beta cells2002